Pharmaceutical News and Articles

Mass Shootings That Claim Most Kids' Lives Are Done by Family Members

parents, aunts and uncles, siblings, grandparents and cousins. In 40 of the cases, the perpetrator was a parent.Much less common was death at the hands of an ac

Sister Study Shows Link Between Pregnancy Complications, Heart Risks

are common but dangerous complications of pregnancy. And numerous studies have shown that experiencing these issues places a woman at higher risk of heart disea

Cancer Rates Are Falling in Appalachia, But Not Enough

Appalachia has a rich history and gorgeous landscapes, but it has also experienced rates of cancer incidence and death that outstrip those of much of the rest o

Can GLP-1 Meds Harm Your Eyes?

Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury s out on whether the medications caused the eye trou

Big Breakfasts Help Keep Heart Patients Happy, Study Shows

were not linked to depression risk, the study found.The bottom line, according to the research team is this W hen you eat is as important as what you eat. Dieta

Breast Cancer: Fear of Recurrence Can Haunt Women for Years

A survey of hundreds of breast cancer survivors finds that tumor recurrence fear can wreak havoc on a woman s emotions. Cancer is all around us. Everything is a

FDA Approves Emblaveo (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data for Isaralgagene Civaparvovec in Fabry Disease

Sangamo Therapeutics, Inc. (Nasdaq SGMO), a genomic medicine company, today announced updated data from the Phase 1 2 STAAR study evaluating isaralgagene civapa

Bracco Imaging Receives FDA Fast Track Designation for BR55

Bracco Imaging, a global leader in diagnostic imaging, announced today that the U.S. FDA has granted Fast Track designation for the development of BR55 (perfluo

Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial evaluat